These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1674917)

  • 1. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures.
    Liljequist S
    Eur J Pharmacol; 1991 Jan; 192(1):197-8. PubMed ID: 1674917
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.
    Rabbani M; Wright J; Butterworth AR; Zhou Q; Little HJ
    Br J Pharmacol; 1994 Jan; 111(1):89-96. PubMed ID: 7912157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.
    Bienkowski P; Stefanski R; Kostowski W
    Eur J Pharmacol; 1996 Oct; 314(3):277-80. PubMed ID: 8957246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus.
    Harvey BH; Jonker LP; Brand L; Heenop M; Stein DJ
    Life Sci; 2002 May; 71(1):43-54. PubMed ID: 12020747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol withdrawal hyperexcitability in vitro is selectively decreased by a competitive NMDA receptor antagonist.
    Ripley TL; Little HJ
    Brain Res; 1995 Nov; 699(1):1-11. PubMed ID: 8616595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol withdrawal seizures and the NMDA receptor complex.
    Grant KA; Valverius P; Hudspith M; Tabakoff B
    Eur J Pharmacol; 1990 Feb; 176(3):289-96. PubMed ID: 2158451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures.
    Valverius P; Crabbe JC; Hoffman PL; Tabakoff B
    Eur J Pharmacol; 1990 Aug; 184(1):185-9. PubMed ID: 2145177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor antagonists inhibit ethanol-produced locomotor stimulation in NMRI mice.
    Liljequist S
    Alcohol; 1991; 8(4):309-12. PubMed ID: 1678606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic site of action underlying the ethanol-induced inhibition of norepinephrine release evoked by stimulation of N-methyl-D-aspartate (NMDA) receptors in rat cerebral cortex.
    Fink K; Göthert M
    Brain Res; 1992 Feb; 572(1-2):27-32. PubMed ID: 1351786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
    Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
    Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK-801 potently inhibits alcohol withdrawal seizures in rats.
    Morrisett RA; Rezvani AH; Overstreet D; Janowsky DS; Wilson WA; Swartzwelder HS
    Eur J Pharmacol; 1990 Jan; 176(1):103-5. PubMed ID: 2155795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.
    Kretschmer BD; Zadow B; Volz TL; Volz L; Schmidt WJ
    J Neural Transm Gen Sect; 1992; 87(1):23-35. PubMed ID: 1346965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist.
    Dunworth SJ; Stephens DN
    Psychopharmacology (Berl); 1998 Apr; 136(3):308-10. PubMed ID: 9566818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of N-methyl-D-aspartate receptor-dependent afterdischarges in rat dentate gyrus following in vitro ethanol withdrawal.
    Morrisett RA
    Neurosci Lett; 1994 Feb; 167(1-2):175-8. PubMed ID: 7909930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.